Background-Nuclear factor κB (NF-κB) is often implicated in contributing to the detrimental effects of cardiac injury.
N uclear factor (NF)-κB is a family of transcription factors intimately involved with the regulation of genes involved in the innate immune response, inflammation, cell survival, and proliferation. 1, 2 Within the heart, NF-κB activation can promote both survival and death pathways. This toggling is related, in part, to the type of stimulus, local cellular environment, canonical versus noncanonical signaling, and activation of cofactors. 3, 4 Multiple studies have demonstrated that strategies aimed at inhibiting NF-κB activity in the face of ischemia-reperfusion can protect the injured heart. [5] [6] [7] [8] Conversely, other evidence supports a cardioprotective role of NF-κB in models of ischemic preconditioning and coronary ligation. 9, 10 As such, understanding the adaptive and maladaptive balance of NF-κB activation remains a largely unanswered question. 11
Clinical Perspective on p 118
Transverse aortic constriction (TAC) is a well-known model with which to study the influence of pressure overload on left ventricular hypertrophy (LVH) and cardiac remodeling. Our group has extended this model by removing the constricting band to examine processes related to pressure-overload-induced HF and its subsequent regression with pressure relief. [12] [13] [14] Within this system, we identified several transcriptional pathways that seem to be significantly involved with both forward and reverse remodeling. 15 In particular, we observed the presence of multiple genes driven by NF-κB, with particular pathways corresponding to different functional phases of the heart. Early after TAC, more genes were associated with cellular proliferation and differentiation; with longer periods of pressure overload and the development of heart failure (HF), there were more genes involved with death pathways. Cumulatively, these studies demonstrate the phenotypic diversity of NF-κB-related signaling.
Conceptually, because NF-κB is such an important component of our innate immunity, the presence of this transcription factor should be essential for normal physiological responses to stress. 16 We tested this hypothesis by administering a potent upstream canonical antagonist of NF-κB activation at the time January 2015 of TAC. 17 Compared with control animals that developed compensatory LVH, mice that received IκB kinase (IKK-β) inhibition more quickly developed decompensated HF. Although others have demonstrated a necessary role of NF-κB in the development of compensatory hypertrophy, [18] [19] [20] [21] many studies point to its importance in promoting cardiac remodeling and HF after pressure overload. [22] [23] [24] Multiple factors have been implicated in the transition from compensatory LVH to decompensated HF. 25, 26 Metabolically, with increased myocardial mass, the cardiomyocyte can outgrow its nutrient vessels, thus subjecting the cell to increased oxidant stress, contractile dysfunction, and death. We have previously demonstrated that the failing human heart has decreased microvascular density. 27 Impaired angiogenesis and dysregulation of hypoxia-inducible factor (HIF) signaling have been implicated in the maladaptive progression of pressure-induced HF. 28, 29 Currently, the relationship between NF-κB and HIF signaling with regard to cardiac remodeling remains largely unknown.
Although several strategies have been used to study the influence of NF-κB on cardiovascular biology, few have provided the specificity to directly interrogate its role. Within its canonical signaling cascade, the sentinel event is generally considered to be the translocation and subsequent binding of the p65 subunit and its activation of its target gene. We recently developed a mouse that has cardiomyocyte-specific absence of p65 NF-κB and demonstrated that when subjected to ischemia-reperfusion, these hearts were protected. 30 In the present study, we sought to determine the effect of pressure overload on mice deficient in p65 NF-κB. We hypothesized that NF-κB is necessary for the development of compensatory adaptation and its absence will accelerate the remodeling process and functional development of HF.
Methods

Animal Model
Mice were generated with cardiomyocyte-specific ablation of p65 NF-κB as previously described. 30 The Cre-loxP system was used in C57Bl/6 mice (Jackson Laboratories). Mice homozygous for the floxed p65 alleles (p65flox/flox) were crossed with mice in which Cre recombinase is expressed under the control of α-myosin heavy chain promoter (MHCCre/+). Both mice were backcrossed with C57BL/6J mice 8×. All animal studies were approved by the Institutional Animal Care and Use Committee, University of Utah.
Surgical Model
Minimally invasive transverse arch banding was performed in 12-to 16-week-old transgenic and wild-type (WT) mice as previously described by our group. 14 In brief, animals were weighed and administered ketamine/xylazine (100 mg/kg; 10 mg/kg). A suprasternal incision was used to expose the transverse arch. TAC was performed using a titanium microclip and applier specifically customized for this procedure (Horizon; Teleflex) and calibrated to a 30G needle. After wound closure, mice were administered 0.15 mg/kg of Buprenorphine SR LABORATORY (Wildlife Pharmaceuticals/Zoopharm) SQ immediately postoperative.
Transthoracic Echocardiography
Transthoracic echocardiography was performed using the Vevo 2100 high-resolution echocardiography machine equipped with a 22-to 55-MHz transducer (VisualSonics; see additional details in the Data Supplement). The standard images that included LV dimensions, wall thickness, volumes, ejections fraction, mass, as well as pressure gradients across the constricted arch were recorded. Coronary blood flow across the left circulation was also calculated ( Figure I in the Data Supplement). All acquisitions were performed by the same experienced operator and analyzed using the VevoStrain software (VisualSonics).
Western Immunoanalysis
Whole hearts or cardiomyocytes were isolated from 8-to 12-weekold WT or p65 knockout mouse as previously described. 30, 31 Western immunoblotting was performed on tissue and cell preparations with the following primary antibodies: p65, phosphorylated p65 NF-κB, GAPDH (Cell Signaling Technology, Inc), β-myosin heavy chain (Sigma), and HIF1α (Novus Bilologics). Secondary peroxidase-conjugated antibody (Cell Signaling Technology, Inc) was applied.
Quantitative Reverse Transcriptase Polymerase Chain Reaction
After RNA isolation, real-time polymerase chain reaction was performed using the QuantStudio 12K Flex System with Power SYBR Green PCR Master Mix (Applied Biosystems). Gene expression levels were calculated in accordance with the 2-ΔΔct method and normalized to 16s.
Histology
Hearts were harvested, fixed for 24 hours at 10% formaldehyde. Seven micrometer longitudinal or cross sections of paraffin-embedded specimens were subjected to hematoxylin-eosin, periodic acid-Schiff), Masson's trichrome staining. Whole-field digital microscopy was performed using the Aperio ScanScope XT (Aperio Technologies) as previously described. 27 A pixel count algorithm with optimized color hue and saturation values (ImageScope 10.0, Aperio Technologies, Inc) was set to accurately identify blue-colored collagen fibers versus red cardiomyocytes, thereby allowing for calculation of percent fibrosis. All histopathologic data were confirmed by a blinded pathologist.
Microvascular Density Evaluation
Endothelial-specific immunohistochemistry staining was performed with biotinylated GSL (Griffonia simplicifolia lectin) I-isolectin B4 (Vector Laboratories, Inc) on freshly cut sections. Whole slide images were analyzed for microvascular density using the Image-Scope 10.0 microvessel analysis algorithm. For capillary domain area (CDA) studies, analyzed images of the tissue for microvessel density were transferred to Image J software (4) . CDAs to determine tissue cross-sectional area that is closer to a given capillary than to any other were defined by creating Voronoi polygons around each vessel using Voronoi tessellation. Capillary domain surface area was measured for each capillary centered polygon and exported to Microsoft excel 2010 (Microsoft) for further analysis ( Figure II in the Data Supplement).
Statistical Analysis
If not specified in the figure legends, exact animal numbers per experiment are provided in Table I in the Data Supplement. Comparisons between experimental groups for serial echocardiographic measurements (Table; Table II in the Data Supplement) were made using 2-way ANOVA with Tukey's multiple comparison post hoc testing using the statistical package, Prism 6.04 (GraphPad). Two-tailed Student t test accommodating for unequal variances was used for comparisons between the 4 experimental groups. Data are expressed as mean±SEM. Statistical significance was declared when we obtained a P value <0.05 from a 2-sided test.
Results
We had previously generated this transgenic mouse and demonstrated adequacy of cardiomyocyte p65 NF-κB deletion embryologically, in vitro and in vivo. 30 However, these studies were performed in the context of ischemia-reperfusion injury. Therefore, we first sought to determine the influence of pressure overload on global NF-κB expression. Whole hearts were evaluated both before and after 6 weeks of pressure overload. Baseline myocardial protein expression for both total and phosphorylated p65 NF-κB was less in transgenic animals ( Figure 1 ). Both groups of animals had increased expression of the active form of NF-κB after TAC, but phosphorylated p65 NF-κB remained lower in the transgenic mouse. The basal and inducible expression of p-p65 in transgenic mice is not unexpected as there are multiple sources of NF-κB besides the cardiomyocyte. Nevertheless, the cardiomyocyte contribution to total NF-κB production seems to be significant and its absence can be correlated to our subsequent phenotypic findings.
To investigate the functional influence of p65 NF-κB deficiency in vivo, mice were subjected to pressure overload and followed up for 6 weeks. We have previously demonstrated the progression of LVH and HF within this model system. [12] [13] [14] [15] Echocardiography demonstrated more profound loss of systolic function in transgenic mice after 6 weeks of pressure overload (Table) . This was associated with left ventricular dilation and increased LV mass and lung congestion ( Figure 2 ). As opposed to the smooth transition into failure seen typically with WT mice, TAC in the p65-deficient mice resulted in a steep loss of function within 1 week ( Figure 2B ; Table II in the Data Supplement). Although TAC increased mRNA expression of classic hypertrophic markers in both groups, β-myosin heavy chain, atrial natriuretic peptide, and brain natriuretic peptide levels were markedly increased in transgenic mice compared with WTs ( Figure 2C ).
We next sought to determine the influence of p65 deficiency on myocardial fibrosis and remodeling. Six weeks after pressure overload, and correlating with our echocardiographic data, p65-deficient hearts were grossly enlarged ( Figure 3A ). Whole heart tissue was stained with Masson's trichrome to examine the levels of fibrosis. As previously described in our human heart samples, 27 digital microscopy with specialized software was used to measure extracellular collagen deposits compared with whole tissue volume ( Figure 3B , microscopic view; Figure III in the Data Supplement, macroscopic view). Transgenic mice had a trend toward increased baseline fibrosis (P=0.07) when compared with WT animals. After TAC, p65 deficiency resulted in more fibrosis compared with its baseline and WT mice ( Figure 3C ).
We next examined the expression of several important fibrosis markers ( Figure 3D ). Absence of cardiomyocyte p65 NF-κB caused no basal differences in Bax/Bcl2, vascular cell adhesion molecule, and periostin expression. There was a trend toward less matrix metallopeptidase-9 and more tissue inhibitor of metallopeptidase 1 expression, but a significant increase in collagen1-α1. After TAC, transgenic mice had enhanced expression of periostin compared with WTs. These results suggest a propensity of mice with cardiomyocytes lacking p65 to have a more aggressive fibrotic response. With regard to apoptosis, we observed no differences after TAC in all groups by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining ( Figure IV in the onlineonly Data Supplement) or Bax/Bcl2 ratios. Although fibrosis is a well-known element of cardiac remodeling, we sought to better understand the mechanism of maladaptive hypertrophy by examining the angiogenic response to pressure overload. Indeed, the imbalance between angiogenesis and muscle volume expansion can provoke oxygen delivery/consumption mismatch with subsequent cellular hypoxia and oxidative stress, further promoting functional decline and HF. 32 Six weeks after TAC, whole heart sections were stained with endothelial-specific markers to quantify microvessel density ( Figure 4A ). There were no baseline differences observed in the respective sham animals. After TAC, mice deficient in p65 NF-κB had lower levels of microvessel density compared with WTs ( Figure 4A and 4C ).
In addition to vascular density, spatial distribution of microvessels is also an important factor influencing tissue oxygen delivery. 33 As such, we examined capillary distribution within myocardial layers. Traversing from the endocardium to the epicardium, there were less endocardial microvessels in transgenic animals after TAC compared with sham, but no differences were noted compared with WT animals after TAC ( Figure V in the Data Supplement). We next sought to determine whether there were changes in geometric capillary spacing by quantifying CDAs (Figure 4B and 4C). Compared with WT hearts, p65 deficiency resulted in a larger CDA. Thus, we can speculate that the larger distances from feeding capillaries to cells contribute to the maladaptive phenotype.
To evaluate the influence of epicardial (inflow) blood flow to the microcirculation, we calculated left main coronary blood flow by echocardiography. These values were normalized to cardiac output and LV mass so as to not confound flow rates by lower ejection fraction and variability in LV mass. As demonstrated in Figure 4D , higher coronary flows were seen immediately after TAC that normalized by 3 weeks and subsequently increased during the ensuing weeks. No differences were observed between groups. These results suggest that changes in coronary inflow blood supply did not affect changes seen at the microvasculature. Having demonstrating that p65-deficient mice have decreased microvascular density associated with enhanced CDA, we next sought to relate NF-κB to mechanisms of angiogenesis ( Figure 5 ). Compared with WT, transgenic mice had decreased baseline expression of several angiogenic markers including vascular endothelial growth factor (VEGF), VEGF receptor-2, and VE-cadherin (VE-CAD). After TAC, no differences were observed between groups in the expression levels of VEGF and VEGF receptor-2, but VE-CAD remained lower in the transgenic animals. Finally, baseline protein expression of HIF1α was markedly lower in mice deficient in cardiomyocyte p65 NF-κB. Although the HIF1α levels increased after TAC in WT mice, HIF1α levels remained lower after TAC in transgenic mice and, furthermore, did not increase from basal expression.
To investigate the earlier events in remodeling, TAC was performed on WT and knockout mice. Hearts were then analyzed by quantitative polymerase chain reaction after 5 days of pressure overload. At this early stage both groups had similar expression of the previously described hypertrophic, fibrosis, and angiogenic markers (data not shown; n=5 animals per group). Perhaps, this time point was too early to detect significant difference to correlate functional decline with microvascular changes, especially within whole heart tissues. As such, we next sought to determine whether p65 deletion created a microenvironment that predisposed the heart to maladaption. TAC was performed and 48 hours later, cardiomyocytes were isolated and examined for p65 NF-κB and HIF1α expression ( Figure 6 ). Compared with WT animals at baseline, transgenic mice had less p65 NF-κB and HIF1α expression. After TAC, HIF1α expression increased in WTs, but the expression of HIF1α in knockout mice remained low. 
Discussion
We demonstrate that cardiomyocyte p65 NF-κB is necessary for the development of compensatory LVH in mice subjected to acute pressure overload. Similar to what we observed with mice that received systemic IKK inhibition, 17 the transgenic animals functionally sped through the adaptive phase of remodeling and went into HF. This observation was associated with increased fibrosis, decreased microvascular density, increased CDA, and decreased expression of HIF1α.
Deciphering the contribution of NF-κB, and its multiple components, to the development of LVH and pressure overload-induced HF remains perplexing and the subject of many reviews during the past decade. 1, 11, 34, 35 Using a variety of approaches, some have demonstrated that NF-κB is required for adaptive hypertrophy at the both cellular and whole heart level. [18] [19] [20] Conversely, others have implicated NF-κB as promoting adverse cardiac remodeling. 5, 22, 23 Our group is responsible for some of this confusion, as we have shown previously that isoproterenol or angiotensin-II-induced LVH is abrogated with NF-κB blockade. 36 Several factors likely are in play, including the microenvironment as well as the intensity and chronicity of stimulus. 11 Others have demonstrated recently the significant role of NF-κB signaling with a similar model system by constructing cardiomyocyte-specific deletions of IKK-β and NEMO (NF-κB essential modulator)/IKK-γ. 21, 37 Both of these proteins are part of the IKK complex and their conditional absence promoted an aggressive development of dilated cardiomyopathy mediated, in part, by dysregulation of the oxidant stress response. Conversely, a gain-of-function approach to overexpress cardiomyocyte-specific IKK-β demonstrated an exaggerated inflammatory response and a dilated cardiomyopathy. 24 These transgenic studies are confounded by the propensity of the mouse hearts to naturally dilate as well as compensatory upregulation of other NF-κBrelated genes, potentially distorting the effects of induced stress (pressure overload) that occurs to nongenetically manipulated animals. Furthermore, IKK subunit deletions influence the function of the entire complex thereby removing specificity that we observed with cardiomyocyte p65-ablation.
One other group has studied a cardiomyocyte-specific p65-deficient mouse. 38 In that elegant study, the authors observed that the absence of p65 NF-κB conferred protection from deleterious remodeling, including decreased cardiomyocyte hypertrophy, heart mass, and fibrosis with preservation of contractile function. Several caveats when comparing our findings must be considered. In their study, TAC was performed on 8-week-old mice and studied after 4 weeks of pressure overload. The response to pressure overload can vary with several factors, including age and sex. In our study, we used 12-week-old mice to avoid some of the variability that we have seen with younger animals. As we have previously shown, the duration of pressure overload is directly associated with the physiological phenotype. 15 As such, one would expect that findings in a 4-week post-TAC mouse would differ from that of a 6-week post-TAC mouse. That said, we saw a precipitous drop in function within a week of TAC (as assessed by 2-dimensional echocardiography), as opposed to the preservation seen in the Liu study (as assessed by fractional shortening). Finally, their transgenic mouse used Cre recombinase under the control of Nkx2.5, whereas our mice were under the control of α-myosin heavy chain. Possibly, a Cre associated with an earlier phase of cardiomyocyte developmental could promote pathways and signals that would not be associated with that seen with αmyosin heavy chain.
We demonstrated that the p65-deficient animals had increased fibrosis. Although the observation that decompensated hearts associated with pressure overload have enhanced fibrosis is not surprising, we sought to implicate the angiogenic influence of cardiomyocyte p65 NF-κB on the maladaptive phenotype. In particular, after TAC, the transgenic animals had decreased microvascular density and enhanced CDA, despite similar epicardial coronary flow. Interestingly, the CDA was increased at baseline in the knockout hearts, portending a larger distance to feed a given cell. In addition to absolute numbers, the quality, location, and size of the vessels likely play an important role in distribution of nutrients. 33, 39 Indeed, increased microvascular density might not be beneficial if its distribution pattern is disorganized, thereby making the distance from the center of a myofibril to the closest vessel beyond the capacity of oxygen diffusion and transport. 32, 39 Although the vascular changes in the transgenic animals might represent epiphenomenon of any maladaptive heart, we further examined the expression of several classic angiogenic factors. Although no differences were observed between groups in the expression levels of VEGF and VEGF receptor-2, VE-CAD was lower in the knockout mice. VE-CAD is a vascular endothelial adhesion molecule that is implicated in capillary leak associated with inflammation. 40 Decreased VE-CAD expression in transgenic mice associated with pressure overload highlights the complex web of the local capillary environment that includes not only microvascular density and geometry but vessel integrity as well. Importantly, the p65-deficient mice had decreased baseline expression of VEGF, VEGF-r2, and VE-CAD. Taken together, these hearts were potentially predisposed to have an altered angiogenic response to hypertrophic stress.
As the master regulator of intracellular oxygen homeostasis, cardiomyocyte HIF family proteins activate different intra/extracellular pathways to regulate oxygen delivery and utilization. HIF-induced angiogenesis will result in mature nonleaky microvessels and influences nitric oxide production, erythropoiesis, cell growth, and differentiation. 41 NF-κB subunit promoter sites have been identified on the HIF1α gene and can regulate the HIF1α response to hypoxic stress in multiple cell types. 42, 43 Although deductively identified in the present study, the relationship linking NF-κB, maladaptive LVH, and HIF1α has heretofore not been convincingly described. HIF1α is an important player in cardiac remodeling after pressure overload and is regulated, in part, by p53 accumulation. 28 Additional circumstantial evidence supports a role between HIF1α and NF-κB as well as p53 and NF-κB. 44, 45 In addition to that indirect linkage, we used a novel approach to provide hypertrophic stress to isolated cardiomyocytes and demonstrate that the p65 deletion abolishes the normal HIF1α response to pressure overload ( Figure 6 ).
Although we have targeted the classic, canonical pathway of NF-κB stimulation, we must acknowledge that other noncanonical signals are active. Indeed, the p50-p105 axis has been shown to alternatively protect from and promote cardiac remodeling in ischemic models. 46, 47 Conversely, we have demonstrated previously with an infarct model that there was no compensatory upregulation of other NF-κB-related proteins in our transgenic mouse. 30 In conclusion, this report adds to the evidence that NF-κB plays an important homeostatic role in cardiac physiology. This approach to NF-κB biology is in line with those that believe in the protective influence of NF-κB and its importance in promoting survival pathways. 48 Mice with cardiomyocyte-specific deletion of p65 NF-κB were unable to mount an adequate angiogenic response to pressure overload and developed rapid, severe HF. As depicted in Figure 7 , this report highlights the influence of NF-κB in the normal, compensatory response to hypertrophic stress. It furthermore provides insight into the pathogenesis of maladaptive HF, and in particular, the regulation of the angiogenic response necessary to maintain a physiological adaptive state.
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Figure 7.
Working model. In a normal cardiomyocyte, hypertrophic stress promotes p65 nuclear factor (NF)-κB translocation to the nucleus and binding of its target transcription factors, including hypoxiainducible factor 1α (HIF1α). HIF1α initiates angiogenic pathways including upregulation of vascular endothelial growth factor (VEGF) that increases microvascular density (MVD) and decreases capillary domain area (CDA), thereby allowing for adequate nutrient/oxygen delivery and adaptive physiological response. In the absence of p65 NF-κB, the cardiomyocyte is unable to enhance HIF1α expression and the angiogenic response is blunted (decreased MVD, and increased CDA). In addition to baseline increased collagen 1α synthesis (Col1α), the p65-deleted cardiomyocyte outgrows its vascular supply, thereby more rapidly progressing to a maladaptive state. VE-CAD indicates VE-cadherin.
